HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 73-84 of 453
Other study type icon
RecruitingNCT07309172

KetoBrain: Brain Energy Metabolism in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Aarhus
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 35 Years
Countries
Denmark
Sponsor
Ole Köhler-Forsberg
Condition
Schizophrenia
Behavioral study icon
RecruitingACTRN12610000467033

Metacognition and Mindfulness: A Group Intervention for Reducing Distress in Early Episode Psychosis

The registry describes this research topic: “Metacognition and Mindfulness: A Group Intervention for Reducing Distress in Early Episode Psychosis”. This is an interventional study.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Sponsor
Murdoch univeristy
Condition
Schizophrenia
Device study icon
RecruitingNCT07196462

Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Nashville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Device study icon
RecruitingACTRN12618000512224

Stimulating social cognition in first-episode psychosis

The registry describes this research topic: “Stimulating social cognition in first-episode psychosis”. This is an interventional study.

Multiple locations, including Herston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceFrom 18 Years to 35 Years
Countries
Australia
Sponsor
The University of Queensland
Condition
Schizophrenia
Drug study icon
RecruitingACTRN12621001434886

Study investigating whether the drug semaglutide could be a safe and effective way of reducing metabolic problems, such as a high Body Mass Index (BMI) and high blood sugar levels, in people with psychosis.

The registry lists this study as recruiting. Study locations are listed in Australia.

In Randwick
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Australia
Sponsor
South Eastern Sydney Local Health District
Condition
Schizophrenia
Drug study icon
RecruitingACTRN12618000413224

The efficacy and mechanisms of action of N-acetylcysteine as an adjunct treatment for first episode psychosis.

The registry describes this research topic: “The efficacy and mechanisms of action of N-acetylcysteine as an adjunct treatment for first episode psychosis”. This is an interventional study.

In Australia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 15 Years to 25 Years
Countries
Australia
Sponsor
Orygen, The National Centre of Excellence in Youth Mental Health
Condition
Schizophrenia
Other study type icon
RecruitingNCT06608706

The Key to Integrated Trauma Treatment in Psychosis study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bergen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 16 Years
Countries
Norway
Sponsor
Haukeland University Hospital
Condition
Schizophrenia
Behavioral study icon
RecruitingACTRN12626000744358

Translating Cognitive Remediation Therapy into Mental Health Practice: Implementing Computerised Interactive Remediation of Cognition and Thinking Skills (CIRCuiTS) for adults with psychosis in Australian public mental health services

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Australia
Sponsor
Charles Sturt University
Condition
Schizophrenia
Other study type icon
RecruitingNCT06278532

Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS

This summary needs review. Please check the official study record and contact the research team for details.

In Kaunas
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, DepressionObservationalFrom 18 Years to 65 Years
Countries
Lithuania
Sponsor
Lithuanian University of Health Sciences
Condition
Schizophrenia, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.